Comparison of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as a Predictor of Clinical Outcome in Acute Ischemic Stroke
Abstract
Highlight:
- NLR and PLR are associated with stroke outcomes
- They may influence outcomes via thromboinflammatory pathways
ABSTRACT
Introduction: Stroke is a clinical syndrome characterized by neurological deficits lasting more than 24 hours or resulting in death, caused exclusively by cerebrovascular disease. Stroke is a leading cause of mortality, responsible for 7.8 million deaths worldwide each year and accounting for 13% of all deaths. Several studies have revealed the role of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in predicting stroke. However, no study has directly compared NLR and PLR levels with the clinical outcomes of acute ischemic stroke (AIS). Objective: This study aims to compare the predictive value of the NLR and PLR with the clinical outcome of AIS based on the Modified Rankin Scale (mRS) and with the incidence of early neurological deterioration (END) based on NIHSS. Method: This was a prospective observational study. NLR and PLR values were obtained from routine blood examinations, and stroke outcome were assessed using the mRS. Result: A total of 125 ischemic stroke patients met the inclusion criteria. Chi-square test showed that NLR was associated with mRS outcomes, with an odds ratio (OR) of 6.1, while PLR was associated with mRS with an OR of 5.6. Fisher's exact test revealed a statistically significant association between NLR and the incidence of END (OR 19.26; p<0.001), as well as between PLR and END (OR 5.9; p=0.003). Conclusion: NLR and PLR have predictive value for both clinical outcome and the incidence of END in patients with acute ischemic stroke.
Full text article
References
1. Coupland AP, Thapar A, Qureshi MI, Jenkins H, Davies AH. The definition of stroke. J R Soc Med. 2017;110(1):9–12. doi: 10.1177/0141076816680121
2. Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review). Int J Mol Med. 2021;49(2):15. doi: 10.3892/ijmm.2021.5070
3. Akbar M, Misbach J, Alfa AY, Syamsudin T, Tjahjadi Mi, Haddani MH, et al. Clinical features of transient ischemic attack or ischemic stroke patients at high recurrence risk in Indonesia. Neurology Asia. 2018; 23(2):107—113. Available at: https://www.neurology-asia.org/articles/neuroasia-2018-23(2)-107.pdf
4. De Meyer SF, Langhauser F, Haupeltshofer S, Kleinschnitz C, Casas AI. Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives. Stroke. 2022;53(5):1487–99. doi: 10.1161/strokeaha.122.038733
5. Rawish E, Nording H, Münte T, Langer HF. Platelets as Mediators of Neuroinflammation and Thrombosis. Front Immunol. 2020;11:548631. doi: 10.3389/fimmu.2020.548631
6. Oyama J ichi, Nagatomo D, Yoshioka G, Yamasaki A, Kodama K, Sato M, et al. The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea. Journal of Cardiology. 2016;67(3):295–302. doi: 10.1016/j.jjcc.2015.06.005
7. Strecker JK, Schmidt A, Schäbitz WR, Minnerup J. Neutrophil granulocytes in cerebral ischemia – Evolution from killers to key players. Neurochemistry International. 2017;107:117–26. doi: 10.1016/j.neuint.2016.11.006
8. Li J, Kim K, Barazia A, Tseng A, Cho J. Platelet–neutrophil interactions under thromboinflammatory conditions. Cell Mol Life Sci. 2015;72(14):2627–43. doi: 10.1007/s00018-015-1845-y
9. Rajakumar I, Vidya TA, Ramachandran K, Hussain A, Aarthi J, Poovitha M, et al. Platelet indices as prognostic markers of ischemic stroke and their correlation with lipid profile. Clin Neurol Neurosurg. 2024;237:108119. doi: 10.1016/j.clineuro.2024.108119
10. Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J, editors. Harrison’s Principles of Internal Medicine. 21st ed. New York: McGraw Hill; 2022.
11. Perez A, Casas S, Tourreilles M, Gonzalez C, Gimenez J, Cabrera L, et al. Neutrophils/Lymphocytes Ratio and Platelets/Lymphocytes Ratio and Its Relationship with Severity and Functional Prognosis in Patients with Acute Ischemic Stroke (P5.235). Neurology. 2016;86(16_supplement):P5.235. doi: 10.1212/WNL.86.16_supplement.P5.235
12. Xu JH, He XW, Li Q, Liu JR, Zhuang MT, Huang FF, et al. Higher Platelet-to-Lymphocyte Ratio Is Associated With Worse Outcomes After Intravenous Thrombolysis in Acute Ischaemic Stroke. Front Neurol. 2019;10:1192. doi: 10.3389/fneur.2019.01192
13. Chen C, Gu L, Chen L, Hu W, Feng X, Qiu F, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke. Front Neurol. 2021;11:525621. doi: 10.3389/fneur.2020.525621
14. Bian J, Guo S, Huang T, Li X, Zhao S, Chu Z, et al. CRP as a potential predictor of outcome in acute ischemic stroke. Biomed Rep. 2023;18(2):17. doi: 10.3892/br.2023.1599
15. Zhang J, Ren Q, Song Y, He M, Zeng Y, Liu Z, et al. Prognostic role of neutrophil–lymphocyte ratio in patients with acute ischemic stroke. Medicine. 2017;96(45):e8624. doi: 10.1097/md.0000000000008624
16. Song SY, Zhao XX, Rajah G, Hua C, Kang R jun, Han Y peng, et al. Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis. Front Neurol. 2019;10:1032. doi: 10.3389/fneur.2019.01032
17. Cui J, Li H, Chen Z, Dong T, He X, Wei Y, et al. Thrombo-Inflammation and Immunological Response in Ischemic Stroke: Focusing on Platelet-Tregs Interaction. Front Cell Neurosci. 2022;16:955385. doi: 10.3389/fncel.2022.955385
18. Simats A, Liesz A. Systemic inflammation after stroke: implications for post‐stroke comorbidities. EMBO Mol Med. 2022;14(9):e16269. doi: 10.15252/emmm.202216269
19. Cui L, Zhang Y, Chen Z, Su Y, Liu Y, Boltze J. Early neutrophil count relates to infarct size and fatal outcome after large hemispheric infarction. CNS Neurosci Ther. 2020;26(8):829–36. doi: 10.1111/cns.13381
20. Wanrooy BJ, Wen SW, Wong CH. Dynamic roles of neutrophils in post‐stroke neuroinflammation. Immunol Cell Biol. 2021;99(9):924–35. doi: 10.1111/imcb.12463
21. Oh SA, Seol SI, Davaanyam D, Kim SW, Lee JK. Platelet-derived HMGB1 induces NETosis, exacerbating brain damage in the photothrombotic stroke model. Mol Med. 2025;31(1):46. doi: 10.1186/s10020-025-01107-7
22. Denorme F, Portier I, Rustad JL, Cody MJ, De Araujo CV, Hoki C, et al. Neutrophil extracellular traps regulate ischemic stroke brain injury. Journal of Clinical Investigation. 2022;132(10):e154225. doi: 10.1172/jci154225
23. Kömürcü HF. The Role of Neutrophils, Lymphocytes, and Platelets in Ischemic Stroke. Boshporus Med J. 2022;9(4):279-285. doi: 10.14744/bmj.2022.48030
24. Xiao J, Qiu Q, Qin C, Tao R, Qiao S, Chen M, et al. Dynamic changes of peripheral blood lymphocyte subsets in acute ischemic stroke and prognostic value. Brain Behav. 2021;11(1):e01919. doi: 10.1002/brb3.1919
25. Pinčáková K, Krastev G, Haring J, Mako M, Mikulášková V, Bošák V. Low Lymphocyte-to-Monocyte Ratio as a Possible Predictor of an Unfavourable Clinical Outcome in Patients with Acute Ischemic Stroke after Mechanical Thrombectomy. Stroke Res Treat. 2022;2022:9243080. doi: 10.1155/2022/9243080
26. Gkantzios A, Kokkotis C, Tsiptsios D, Moustakidis S, Gkartzonika E, Avramidis T, et al. From Admission to Discharge: Predicting National Institutes of Health Stroke Scale Progression in Stroke Patients Using Biomarkers and Explainable Machine Learning. J Pers Med. 2023;13(9):1375. doi: 10.3390/jpm13091375
27. Geng HH, Wang Q, Li B, Cui BB, Jin YP, Fu RL, et al. Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke. Medicine. 2017;96(51):e9068. https://doi.org/10.1097/md.0000000000009068
28. Nam KW, Kim TJ, Lee JS, Park SH, Jeong HB, Yoon BW, et al. Neutrophil-to-lymphocyte ratio predicts early worsening in stroke due to large vessel disease. PLoS ONE. 2019;14(8):e0221597. doi: 10.1371/journal.pone.0221597
29. Liu H, Liu K, Zhang K, Zong C, Yang H, Li Y, et al. Early neurological deterioration in patients with acute ischemic stroke: a prospective multicenter cohort study. Ther Adv Neurol Disord. 2023;16:17562864221147743. doi:10.1177/17562864221147743
30. De Meyer SF, Denorme F, Langhauser F, Geuss E, Fluri F, Kleinschnitz C. Thromboinflammation in Stroke Brain Damage. Stroke. 2016;47(4):1165–72. doi: 10.1161/strokeaha.115.011238
Authors
Copyright (c) 2025 Anthony Gunawan, Ashari Bahar, Irbab Hawari, Wijoyo Halim

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.